RYAN MORGAN: Open Payments
NPI 1033454616 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$110,578 in 169 payments from 15 companies in 2025. Trend: 2023 $44,629 · 2024 $43,672 · 2025 $110,578
Speaker / faculty: $64,225Consulting: $41,790Travel & lodging: $1,992Honoraria: $1,287Food & beverage: $1,267Education: $19
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 119 | $66,769 |
| Kedplasma LLC | 12 | $39,000 |
| Novo Nordisk Inc | 9 | $2,959 |
| Rhythm Pharmaceuticals, Inc. | 4 | $1,352 |
| ABBVIE INC. | 7 | $150 |
| Madrigal Pharmaceuticals | 5 | $116 |
| Novartis Pharmaceuticals Corporation | 3 | $47 |
| Corcept Therapeutics | 2 | $45 |
| Amgen Inc. | 2 | $40 |
| Alexion Pharmaceuticals, Inc. | 1 | $22 |
Products named: ZEPBOUND, IMCIVREE, REZDIFFRA, Ozempic, MOUNJARO, Wegovy, CREON, LEQVIO.
Industry payments across OK — which companies pay providers there.
